Involvement of cytochrome P450 enzymes in inflammation and cancer: a review Maria Carolina StippAlexandra Acco Review Article 28 October 2020 Pages: 295 - 309
The use of zebrafish model in prostate cancer therapeutic development and discovery Haneen AmawiAlaa A. A. AljabaliAmit K. Tiwari Review Article 03 January 2021 Pages: 311 - 325
Irinotecan-induced intestinal mucositis in mice: a histopathological study Thaise BoeingMarcelo Biondaro GoisLuisa Mota da Silva Original Article 31 October 2020 Pages: 327 - 336
A phase I trial of temsirolimus and erlotinib in patients with refractory solid tumors Haeseong ParkKerry WilliamsAndrea Wang-Gillam Original Article 06 November 2020 Pages: 337 - 347
A Phase 1 randomized study compare the pharmacokinetics, safety and immunogenicity of HLX02 to reference CN- and EU-sourced trastuzumab in healthy subjects X. ZhuY. DingQ. Zhang Original Article 09 November 2020 Pages: 349 - 359
Interactions between anti-EGFR therapies and cytotoxic chemotherapy in oesophageal squamous cell carcinoma: why clinical trials might have failed and how they could succeed Madusha MeemanageLindsay C. SpenderRussell D. Petty Original Article Open access 09 November 2020 Pages: 361 - 377
Effects of thymidylate synthase polymorphisms on toxicities associated with high-dose methotrexate in childhood acute lymphoblastic leukemia Abrar Al-SheikhAl-Motassem YousefRand Farhad Original Article 10 November 2020 Pages: 379 - 385
A phase 1 pharmacokinetic study of oral NEPA, the fixed combination of netupitant and palonosetron, in Chinese healthy volunteers Rui ChenHongyun WangPei Hu Original Article 02 January 2021 Pages: 387 - 396
FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a multicenter, retrospective study Kumiko UmemotoHideaki TakahashiMasafumi Ikeda Original Article Open access 02 January 2021 Pages: 397 - 404
FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway Ya-Kun LiuYa-Jing JiaJing Ma Original Article 03 January 2021 Pages: 405 - 414
Antitumor activity and mechanism of resistance of the novel HDAC and PI3K dual inhibitor CUDC-907 in pancreatic cancer Shuang LiuShoujing ZhaoGuan Wang Original Article 03 January 2021 Pages: 415 - 423
Pingyangmycin enhances the antitumor efficacy of anti-PD-1 therapy associated with tumor-infiltrating CD8+ T cell augmentation Chuan-Kun ShanYi-Bo DuYong-Su Zhen Original Article 03 January 2021 Pages: 425 - 436
BRAF/MEK inhibitors for BRAF V600E-mutant cancers in non-approved setting: a case series Sabeeh-ur-Rehman ButtAlberto MejiasHendrik-Tobias Arkenau Short Communication 03 February 2021 Pages: 437 - 441